OWCompany report
Blue Owl Capital Inc. OWL
The bet you're really making is that Blue Owl keeps gathering more money to manage, most of it lent to mid-size companies that banks no longer serve, and keeps taking a yearly fee on that money its clients cannot easily pull back. Underneath, you're betting the money stays locked up for years or for good, so the fees keep arriving even when markets fall, and that private lending stays in demand as more of it chases the same borrowers. Right now it is going flat: sales have sat near $753 million for three straight quarters, up 7% from a year ago after years near 30%, and almost every dollar of cash earnings goes back out as dividend. You pay about 14 times those cash earnings, near the low end of the past year and well under the roughly 22 times investors paid at last autumn's high near $19.
Key data
OWL · price with moving averages
Source: market data.
The business
Blue Owl runs three money-management engines on top of a base of capital that mostly cannot walk out the door. The largest is direct lending: it makes loans to mid-size companies that have grown too large for a bank branch and too small for the bond market, and collects a fee on every dollar it manages. The second buys minority stakes in other private-capital firms, the old Dyal business, plus a growing book of stakes in professional sports teams. The third does sale-leasebacks, buying a company's building and renting it back on a long triple-net lease. The thing that makes this more than a fee shop is the shape of the capital: much of it is permanent or locked for a decade, so the management fee behaves like a subscription that renews itself rather than money that flees when prices drop. That locked, recurring fee base is the moat, and it is the whole reason a plateau in new fundraising does not immediately dent earnings.
The numbers
Revenue climbed for years, then stopped. The last five quarters show the plateau plainly, and the split between reported profit and cash earnings shows the ownership structure underneath it.
| Period | Revenue | GAAP dil. EPS | Adj. DE/sh |
|---|---|---|---|
| Q2 2025 | $703.1M | $0.02 | $0.21 |
| Q3 2025 | $728.0M | $0.01 | $0.22 |
| Q4 2025 | $755.6M | $0.07 | $0.24 |
| Q1 2026 | $753.8M | $0.02 | $0.19 |
| Q2 2026 | $753.1M | $0.02 | $0.22 |
Three quarters glued near $753 million is the story the headline hides. Cash earnings per share peaked at $0.24 in the fourth quarter, sagged to $0.19, and clawed back to $0.22. The reported EPS is a sliver of that because most of the profit flows to the pre-IPO owners under the company's Up-C structure, which is why the reported multiple reads near 99 times while the cash multiple is about 14. The reacceleration the market keeps waiting for has not arrived on the top line.
| Period | Revenue | GAAP dil. EPS |
|---|---|---|
| FY2021 | $823.9M | -$0.93 |
| FY2022 | $1,369.7M | -$0.02 |
| FY2023 | $1,731.6M | $0.11 |
| FY2024 | $2,295.4M | $0.20 |
| FY2025 | $2,870.2M | $0.12 |
| 2026, 1H | $1,506.9M | $0.04 |
The share count is the tell. Diluted shares went from 433 million in 2022 to 665 million in 2025 and 689 million now, up 53% in three years, issued to buy the platforms that drove the revenue. Free cash flow nearly quadrupled to $1.2 billion over that span, but per share it crawled from $1.53 in 2022 to $1.80 in 2025, a 5.6% annual rate against 28% revenue growth. You are buying a business that compounds impressively in total and only modestly per share, because it pays for its growth in its own stock. The non-obvious read is that the dilution engine is slowing while fees on capital already raised keep switching on, so per-share cash earnings can inflect up even with flat fundraising. The print that settles it is distributable earnings per share above $0.24 for two straight quarters with the share count holding still.
Management
The clearest signal in the file is that three of the most senior people bought stock with their own money. Ostrover, Packer, and Lipschultz together bought about $4.4 million on the same December 2025 day, part of nine open-market purchases totaling $6.0 million over twelve months against zero sales, all discretionary buys near today's depressed price rather than scheduled sales. Against that, the buyback record runs backward: the company repurchased $53.7 million at an average $18.86 in 2025 and $38.8 million at $18.99 in 2024, buying its own shares high while insiders now buy low. Pay is heavy, with $18.5 million to Ostrover in 2023, and the 2021 combination handed founders enormous equity, a reminder that public holders sit behind pre-IPO owners here. Adjusted earnings have come in at or just above the published estimate in each of the last eight quarters.
How it fails or surprises you
The credit cycle turns. The biggest engine lends to mid-size companies, and that book has never been tested through a real default wave since it scaled. A recession that pushes borrowers into non-accrual shrinks the fee-paying base and kills performance fees at once. Watch non-accruals in the lending vehicles' filings and any markdown in the credit funds. That is where the annuity leaks first.
The dividend outruns the cash that funds it. The company pays out essentially everything: $0.91 a year against roughly $0.87 of trailing distributable earnings. The prior watch-item, cash earnings per share against the payout, held but only barely, with Q2's $0.22 sitting right on the dividend line rather than pulling ahead. If per-share earnings stay flat instead of rising, the payout is uncovered and the 7.7% yield is the only thing holding the price. This is the number that would prove a durable-annuity read wrong.
Private credit keeps draining the banks (right tail). If insurance mandates and wealth-channel money ramp as the pipeline suggests, fee-paying assets could reaccelerate to the mid-teens with no fresh share issuance, and per-share cash earnings break above $0.24. The market pays nothing for this today because the top line is flat. The first proof is fundraising inflows turning up two quarters running.
Closing thoughts
This is mostly an uncertainty a named print resolves: whether per-share cash earnings can climb off the plateau. If the locked fees turn on and issuance slows, the stock re-rates from about 14 times back toward the low-20s multiple it carried a year ago, with a 7.7% yield paid to wait. If growth is genuinely stalled and a credit cycle bites, the dividend is the fuse and there is little cushion beneath it. The left tail is a barely-covered payout meeting a credit downturn. The right tail is a permanent fee base compounding per share while the market still prices a plateau. As judgment, not arithmetic, the insider buying and the locked capital tilt the odds toward the right tail, but the flat top line means the market is not wrong to want proof first.
The bet is still that Blue Owl keeps gathering money to manage, keeps lending it to mid-size companies, and keeps collecting a fee its clients cannot easily pull. What breaks it is the dividend outrunning the cash earnings that fund it while a credit downturn thins the fee base. The one pair of numbers that tells you first is distributable earnings per share against the $0.91 dividend, quarter by quarter. If per-share earnings cannot climb above the payout, the thesis was a plateau wearing a growth story's clothes.
Methodology
Sector frame: alternative asset management, permanent-capital fee annuity, Up-C structure separating reported profit from cash earnings.
Data gaps: adjusted distributable earnings per share figures are company-disclosed non-GAAP metrics not included in FMP data; stated quarterly and TTM figures (including the $0.87 TTM sum) were not independently verified against earnings release PDFs this run. No multi-year P/E series in the pack, so the valuation-range comparison is derived from the 52-week price range against trailing cash earnings and labeled as such.
Bundle: Q2 2026 results filed 2026-07-31, fiscal 2025 results filed 2026-02-19, vendor market data as of 2026-09-06.
Sources: SEC EDGAR filings as named; price, insider transactions, and estimates from vendor market data.
Fact check: all GAAP revenue, EPS, share count, FCF, insider transactions, executive compensation, dividend, and valuation multiples reconciled to FMP data and cited filings with zero corrections required. Adjusted distributable earnings figures (non-GAAP, company-specific metric) not independently verified against earnings releases; other calculations tied out within rounding. Final analysis verified as of Sep 6, 2026.
Bid Cap
Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.
Subscribe on Substack


